2022 ´ëÇÑ°©»ó¼±³»ºÐºñ¿Ü°úÇÐȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷) : 2022-04-09±³À°ÀÏÀÚ : 2022-04-09
±³À°Àå¼Ò : È£ÅÚÀÎÅͺҰí ÄÁº¥¼ÇȦ
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà)2022 ´ëÇÑ°©»ó¼±³»ºÐºñ¿Ü°úÇÐȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑ°©»ó¼±³»ºÐºñ¿Ü°úÇÐȸ
´ã´çÀÚ : ±èÀº¿µ
¿¬¶ôó : 02-501-2988
À̸ÞÀÏ :
kates1996@naver.com ±³À°Á¾·ù : ¿Ü°ú
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
´ë±¸±¤¿ª½Ã±³À°½Ã°£ : 9 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 100,000¿ø
ºñ°í Á¤È¸¿ø : 7¸¸¿ø, 9¸¸¿ø(ÇöÀå) Àü°øÀÇ : 5¸¸¿ø, 7¸¸¿ø(ÇöÀå) ºñȸ¿ø : 8¸¸¿ø, 10¸¸¿ø(ÇöÀå)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 04-09 ÄÁº¥¼ÇȦ 08:50~09:00 Opening Remark ()
±³À°½Ã°£ 04-09 ÄÁº¥¼ÇȦ 09:00~10:10 Free Paper III(Recent advances in endocrine surgery) ³²±âÇö(¿¬¼¼ÀÇ´ë)
ÈÞ½Ä 04-09 10:10~10:30 Break ()
±³À°½Ã°£ 04-09 ÄÁº¥¼ÇȦ 10:30~11:00 New WHO(World Health Organization) classification of thyroid neoplasm ¿øÀç°æ(¼¿ïÀÇ´ë º´¸®°ú)
±³À°½Ã°£ 04-09 ÄÁº¥¼ÇȦ 11:00~11:30 2021 Revised K-TIRADS(Korean-thyroid imaging reporting and data system) ÇÏÀºÁÖ(¾ÆÁÖÀÇ´ë ¿µ»óÀÇÇаú)
±³À°½Ã°£ 04-09 ÄÁº¥¼ÇȦ 11:30~12:00 °©»ó¼±¾Ï¿¡¼ TERT(Telomerase reverse trans) mutation °Ë»ç ÇöȲ ¹× ¿¹ÈÄ Á¤Âù±Ç(°¡Å縯ÀÇ´ë º´¸®°ú)
±âŸ 04-09 ÄÁº¥¼ÇȦ 12:00~12:20 General Assembly (ÃÑȸ) ()
½Ä»ç 04-09 12:20~13:20 Á¡½É ()
±³À°½Ã°£ 04-09 ÄÁº¥¼ÇȦ 13:20~14:10 CAR-T(chimeric antigen receptor T cell) therapy in advanced thyroid cancer Thomas Fahey(Weill Cornell Medicine USA)
±³À°½Ã°£ 04-09 ÄÁº¥¼ÇȦ 14:10~14:40 Good surgical technique in endocrine surgery ¹®º´ÀÎ(ÀÌÈÀÇ´ë)
ÈÞ½Ä 04-09 14:40~15:00 Break ()
±³À°½Ã°£ 04-09 ÄÁº¥¼ÇȦ 15:00~15:10 Active surveillance ±è¿ø±¸(¿ï»êÀÇ´ë ³»°ú)
±³À°½Ã°£ 04-09 ÄÁº¥¼ÇȦ 15:10~15:20 Surgery ³²±âÇö(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04-09 ÄÁº¥¼ÇȦ 15:20~15:30 Radiofrequency ablation °°æÈ£(ÀÌÈÀÇ´ë)
Åä·Ð 04-09 ÄÁº¥¼ÇȦ 15:30~16:10 Case Discussion ()
±³À°½Ã°£ 04-09 ÄÁº¥¼ÇȦ 16:10~16:30 Isthmusectomy in patients with papillary thyroid carcinoma ÀÌ¿ë»ó(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04-09 ÄÁº¥¼ÇȦ 16:30~16:50 Hypothyroidism after lobectomy ±è¿Ï¿í(°æºÏÀÇ´ë)
±³À°½Ã°£ 04-09 ÄÁº¥¼ÇȦ 16:50~17:10 Postoperatively diagnosed poorly differentiated carcinoma À±ÇöÁ¶(ÀüºÏÀÇ´ë)
±âŸ 04-09 17:10~17:20 Closing Remark, ½Ã»ó ()
±³À°½Ã°£ 04-09 ÄÁº¥¼ÇȦ2 09:00~09:20 Molecular basis of parathyroid disease À̽ÃÈÆ(°¡ÃµÀÇ´ë ³»°ú)
±³À°½Ã°£ 04-09 ÄÁº¥¼ÇȦ2 09:20~09:40 Parathyroid carcinoma ±è¿¬¼±(µ¿°º´¿ø)
±³À°½Ã°£ 04-09 ÄÁº¥¼ÇȦ2 09:40~10:00 Management of secondary/tertiary hyperparathyroidism Á¤Á¾ÁÖ(¿¬¼¼ÀÇ´ë)
Åä·Ð 04-09 ÄÁº¥¼ÇȦ2 10:00~10:00 Discussion ()
±³À°½Ã°£ 04-09 ÄÁº¥¼ÇȦ2 10:30~10:50 ¼ö¼ú ÀüÈÄ ¿Ü·¡¿¡¼ °©»ó¼± ÄÚµð³×ÀÌÅÍÀÇ ¿ªÇÒ ¹Ú°æ¾Æ(°³²¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 04-09 ÄÁº¥¼ÇȦ2 10:50~11:10 ¼ö¼ú½Ç¿¡¼ Àü´ã°£È£»çÀÇ ¿ªÇÒ ¹ÚÈñ¿¬(ȼøÀü³²´ëÇб³º´¿ø)
±³À°½Ã°£ 04-09 ÄÁº¥¼ÇȦ2 11:10~11:30 °©»ó¼± ¼ö¼ú ÈÄ º´µ¿¿¡¼ °£È£»çÀÇ ¿ªÇÒ È²Àº°æ(¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 04-09 ÄÁº¥¼ÇȦ2 15:00~15:20 Discordant results between USG(ultrasonography) and FNA(fine needle aspiration) Á¤¿µÁÖ(´ë±¸°¡Å縯ÀÇ´ë ¿Ü°ú)
±³À°½Ã°£ 04-09 ÄÁº¥¼ÇȦ2 15:20~15:40 Diagnosis and management of thyroid functional disorder during pregnancy ¹®Áؼº(¿µ³²ÀÇ´ë ³»ºÐºñ³»°ú)
±³À°½Ã°£ 04-09 ÄÁº¥¼ÇȦ2 15:40~16:00 Indications and complications of thyroid radio frequency ablation(RFA) Á¶¿ìÁø(À§µå½ÉÀÇ¿ø)
Åä·Ð 04-09 16:00~16:10 Discussion ()